Intrinsic value of Chemours - CC

Previous Close

$35.09

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$35.09

 
Intrinsic value premium content
 
Up/down potential premium content
 
Rating premium content
 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of CC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 6.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  -5.54
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  5,400
  5,508
  5,635
  5,779
  5,942
  6,122
  6,320
  6,535
  6,768
  7,019
  7,288
  7,577
  7,884
  8,212
  8,560
  8,929
  9,320
  9,734
  10,172
  10,635
  11,124
  11,639
  12,183
  12,756
  13,360
  13,996
  14,666
  15,371
  16,112
  16,893
  17,714
Variable operating expenses, $m
 
  5,634
  5,764
  5,911
  6,077
  6,261
  6,463
  6,682
  6,920
  7,176
  7,451
  7,729
  8,043
  8,377
  8,732
  9,109
  9,508
  9,931
  10,377
  10,850
  11,348
  11,874
  12,429
  13,013
  13,630
  14,278
  14,962
  15,681
  16,437
  17,233
  18,071
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  5,474
  5,634
  5,764
  5,911
  6,077
  6,261
  6,463
  6,682
  6,920
  7,176
  7,451
  7,729
  8,043
  8,377
  8,732
  9,109
  9,508
  9,931
  10,377
  10,850
  11,348
  11,874
  12,429
  13,013
  13,630
  14,278
  14,962
  15,681
  16,437
  17,233
  18,071
Operating income, $m
  -74
  -126
  -129
  -132
  -135
  -139
  -143
  -147
  -152
  -157
  -162
  -153
  -159
  -166
  -173
  -180
  -188
  -196
  -205
  -214
  -224
  -235
  -246
  -257
  -269
  -282
  -296
  -310
  -325
  -341
  -357
EBITDA, $m
  210
  164
  168
  172
  177
  182
  188
  194
  201
  209
  217
  225
  235
  244
  255
  266
  277
  290
  303
  316
  331
  346
  362
  379
  397
  416
  436
  457
  479
  502
  527
Interest expense (income), $m
  208
  194
  128
  134
  140
  148
  157
  166
  176
  187
  199
  212
  225
  240
  255
  272
  289
  308
  327
  348
  370
  393
  417
  443
  470
  499
  529
  560
  594
  629
  666
Earnings before tax, $m
  -11
  -320
  -256
  -265
  -275
  -287
  -299
  -313
  -328
  -344
  -361
  -364
  -384
  -405
  -428
  -452
  -477
  -504
  -532
  -563
  -594
  -628
  -663
  -700
  -740
  -781
  -825
  -870
  -919
  -970
  -1,023
Tax expense, $m
  -18
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  7
  -320
  -256
  -265
  -275
  -287
  -299
  -313
  -328
  -344
  -361
  -364
  -384
  -405
  -428
  -452
  -477
  -504
  -532
  -563
  -594
  -628
  -663
  -700
  -740
  -781
  -825
  -870
  -919
  -970
  -1,023

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  902
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,060
  5,261
  5,382
  5,520
  5,675
  5,847
  6,036
  6,242
  6,464
  6,704
  6,961
  7,237
  7,530
  7,843
  8,175
  8,528
  8,902
  9,297
  9,716
  10,158
  10,624
  11,117
  11,636
  12,184
  12,760
  13,368
  14,007
  14,681
  15,389
  16,134
  16,918
Adjusted assets (=assets-cash), $m
  5,158
  5,261
  5,382
  5,520
  5,675
  5,847
  6,036
  6,242
  6,464
  6,704
  6,961
  7,237
  7,530
  7,843
  8,175
  8,528
  8,902
  9,297
  9,716
  10,158
  10,624
  11,117
  11,636
  12,184
  12,760
  13,368
  14,007
  14,681
  15,389
  16,134
  16,918
Revenue / Adjusted assets
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
  1.047
Average production assets, $m
  2,994
  3,051
  3,122
  3,202
  3,292
  3,392
  3,501
  3,620
  3,750
  3,889
  4,038
  4,197
  4,368
  4,549
  4,742
  4,947
  5,163
  5,393
  5,635
  5,892
  6,163
  6,448
  6,749
  7,067
  7,402
  7,754
  8,125
  8,515
  8,926
  9,359
  9,813
Working capital, $m
  782
  -105
  -107
  -110
  -113
  -116
  -120
  -124
  -129
  -133
  -138
  -144
  -150
  -156
  -163
  -170
  -177
  -185
  -193
  -202
  -211
  -221
  -231
  -242
  -254
  -266
  -279
  -292
  -306
  -321
  -337
Total debt, $m
  3,544
  2,319
  2,428
  2,552
  2,692
  2,847
  3,017
  3,202
  3,402
  3,618
  3,849
  4,097
  4,361
  4,643
  4,942
  5,259
  5,595
  5,952
  6,328
  6,726
  7,146
  7,589
  8,057
  8,549
  9,068
  9,615
  10,191
  10,797
  11,434
  12,105
  12,811
Total liabilities, $m
  5,960
  4,735
  4,844
  4,968
  5,108
  5,263
  5,433
  5,618
  5,818
  6,034
  6,265
  6,513
  6,777
  7,059
  7,358
  7,675
  8,011
  8,368
  8,744
  9,142
  9,562
  10,005
  10,473
  10,965
  11,484
  12,031
  12,607
  13,213
  13,850
  14,521
  15,227
Total equity, $m
  100
  526
  538
  552
  568
  585
  604
  624
  646
  670
  696
  724
  753
  784
  818
  853
  890
  930
  972
  1,016
  1,062
  1,112
  1,164
  1,218
  1,276
  1,337
  1,401
  1,468
  1,539
  1,613
  1,692
Total liabilities and equity, $m
  6,060
  5,261
  5,382
  5,520
  5,676
  5,848
  6,037
  6,242
  6,464
  6,704
  6,961
  7,237
  7,530
  7,843
  8,176
  8,528
  8,901
  9,298
  9,716
  10,158
  10,624
  11,117
  11,637
  12,183
  12,760
  13,368
  14,008
  14,681
  15,389
  16,134
  16,919
Debt-to-equity ratio
  35.440
  4.410
  4.510
  4.620
  4.740
  4.870
  5.000
  5.130
  5.260
  5.400
  5.530
  5.660
  5.790
  5.920
  6.040
  6.170
  6.290
  6.400
  6.510
  6.620
  6.730
  6.830
  6.920
  7.020
  7.110
  7.190
  7.280
  7.350
  7.430
  7.500
  7.570
Adjusted equity ratio
  -0.155
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  7
  -320
  -256
  -265
  -275
  -287
  -299
  -313
  -328
  -344
  -361
  -364
  -384
  -405
  -428
  -452
  -477
  -504
  -532
  -563
  -594
  -628
  -663
  -700
  -740
  -781
  -825
  -870
  -919
  -970
  -1,023
Depreciation, amort., depletion, $m
  284
  290
  297
  304
  312
  321
  331
  341
  353
  366
  379
  378
  393
  410
  427
  446
  465
  486
  508
  531
  555
  581
  608
  637
  667
  699
  732
  767
  804
  843
  884
Funds from operations, $m
  1,078
  -30
  40
  38
  36
  34
  31
  28
  25
  22
  18
  14
  9
  4
  -1
  -6
  -12
  -18
  -25
  -32
  -39
  -47
  -55
  -64
  -73
  -82
  -93
  -103
  -115
  -126
  -139
Change in working capital, $m
  484
  -2
  -2
  -3
  -3
  -3
  -4
  -4
  -4
  -5
  -5
  -5
  -6
  -6
  -7
  -7
  -7
  -8
  -8
  -9
  -9
  -10
  -10
  -11
  -11
  -12
  -13
  -13
  -14
  -15
  -16
Cash from operations, $m
  594
  -221
  42
  41
  39
  37
  35
  33
  30
  26
  23
  19
  15
  11
  6
  1
  -5
  -10
  -16
  -23
  -30
  -37
  -45
  -53
  -61
  -70
  -80
  -90
  -100
  -112
  -123
Maintenance CAPEX, $m
  0
  -270
  -275
  -281
  -288
  -297
  -306
  -315
  -326
  -338
  -350
  -364
  -378
  -393
  -410
  -427
  -446
  -465
  -486
  -508
  -531
  -555
  -581
  -608
  -637
  -667
  -699
  -732
  -767
  -804
  -843
New CAPEX, $m
  -338
  -57
  -70
  -80
  -90
  -100
  -110
  -119
  -129
  -139
  -149
  -160
  -170
  -181
  -193
  -205
  -217
  -229
  -243
  -256
  -271
  -286
  -301
  -318
  -335
  -352
  -371
  -390
  -411
  -432
  -455
Cash from investing activities, $m
  357
  -327
  -345
  -361
  -378
  -397
  -416
  -434
  -455
  -477
  -499
  -524
  -548
  -574
  -603
  -632
  -663
  -694
  -729
  -764
  -802
  -841
  -882
  -926
  -972
  -1,019
  -1,070
  -1,122
  -1,178
  -1,236
  -1,298
Free cash flow, $m
  951
  -548
  -303
  -320
  -339
  -359
  -380
  -402
  -426
  -450
  -477
  -504
  -533
  -564
  -597
  -631
  -667
  -705
  -745
  -787
  -831
  -878
  -927
  -978
  -1,033
  -1,090
  -1,149
  -1,212
  -1,279
  -1,348
  -1,421
Issuance/(repayment) of debt, $m
  -381
  -1,210
  109
  124
  140
  155
  170
  185
  200
  216
  232
  248
  264
  281
  299
  317
  336
  356
  377
  398
  420
  443
  467
  493
  519
  547
  576
  606
  638
  671
  706
Issuance/(repurchase) of shares, $m
  11
  2,185
  206
  210
  215
  221
  229
  238
  248
  259
  271
  284
  299
  314
  331
  349
  368
  389
  410
  433
  458
  484
  511
  540
  571
  604
  638
  674
  712
  752
  794
Cash from financing (excl. dividends), $m  
  -374
  975
  315
  334
  355
  376
  399
  423
  448
  475
  503
  532
  563
  595
  630
  666
  704
  745
  787
  831
  878
  927
  978
  1,033
  1,090
  1,151
  1,214
  1,280
  1,350
  1,423
  1,500
Total cash flow (excl. dividends), $m
  558
  -1,759
  -194
  -196
  -199
  -204
  -210
  -217
  -225
  -235
  -245
  -257
  -269
  -283
  -298
  -314
  -331
  -349
  -368
  -389
  -411
  -435
  -459
  -486
  -513
  -543
  -574
  -606
  -641
  -677
  -716
Retained Cash Flow (-), $m
  26
  -1,313
  -12
  -14
  -16
  -17
  -19
  -21
  -22
  -24
  -26
  -28
  -29
  -31
  -33
  -35
  -37
  -40
  -42
  -44
  -47
  -49
  -52
  -55
  -58
  -61
  -64
  -67
  -71
  -75
  -78
Prev. year cash balance distribution, $m
 
  887
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Discount rate, %
 
  11.80
  12.39
  13.01
  13.66
  14.34
  15.06
  15.81
  16.60
  17.43
  18.31
  19.22
  20.18
  21.19
  22.25
  23.36
  24.53
  25.76
  27.05
  28.40
  29.82
  31.31
  32.87
  34.52
  36.24
  38.06
  39.96
  41.96
  44.05
  46.26
  48.57
PV of cash for distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100
  50.0
  48.1
  46.3
  44.6
  42.9
  41.3
  39.7
  38.2
  36.7
  35.3
  33.9
  32.6
  31.3
  30.0
  28.8
  27.6
  26.4
  25.3
  24.2
  23.2
  22.2
  21.2
  20.3
  19.4
  18.5
  17.6
  16.8
  16.1
  15.3
  14.6

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide (TiO2) under the Ti-Pure brand name to deliver whiteness, brightness, opacity, and protection in various applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, PVC window profiles, laminate papers, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, industrial fluoropolymer resins, coatings, and other downstream products under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers, and other industries. This segment provides mining solutions; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

FINANCIAL RATIOS  of  Chemours (CC)

Valuation Ratios
P/E Ratio 915.3
Price to Sales 1.2
Price to Book 64.1
Price to Tangible Book
Price to Cash Flow 10.8
Price to Free Cash Flow 25
Growth Rates
Sales Growth Rate -5.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -34.9%
Cap. Spend. - 3 Yr. Gr. Rate -5.1%
Financial Strength
Quick Ratio 60
Current Ratio 0
LT Debt to Equity 3529%
Total Debt to Equity 3544%
Interest Coverage 1
Management Effectiveness
Return On Assets -2%
Ret/ On Assets - 3 Yr. Avg. 1.4%
Return On Total Capital 0.2%
Ret/ On T. Cap. - 3 Yr. Avg. 3.2%
Return On Equity 6.2%
Return On Equity - 3 Yr. Avg. 4.4%
Asset Turnover 0.9
Profitability Ratios
Gross Margin 20.6%
Gross Margin - 3 Yr. Avg. 19.5%
EBITDA Margin 8.9%
EBITDA Margin - 3 Yr. Avg. 8.2%
Operating Margin -1.4%
Oper. Margin - 3 Yr. Avg. 1.4%
Pre-Tax Margin -0.2%
Pre-Tax Margin - 3 Yr. Avg. 1.7%
Net Profit Margin 0.1%
Net Profit Margin - 3 Yr. Avg. 1.6%
Effective Tax Rate 163.6%
Eff/ Tax Rate - 3 Yr. Avg. 81%
Payout Ratio 314.3%

CC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CC stock intrinsic value calculation we used $5400 million for the last fiscal year's total revenue generated by Chemours. The default revenue input number comes from 2016 income statement of Chemours. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CC stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 11.8%, whose default value for CC is calculated based on our internal credit rating of Chemours, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Chemours.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CC stock the variable cost ratio is equal to 102.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for CC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.5% for Chemours.

Corporate tax rate of 27% is the nominal tax rate for Chemours. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CC are equal to 55.4%.

Life of production assets of 11.1 years is the average useful life of capital assets used in Chemours operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CC is equal to -1.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $100 million for Chemours - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 182.316 million for Chemours is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Chemours at the current share price and the inputted number of shares is $6.4 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
DD E.I. DuPont de 80.69 prem.  prem.
MMM 3M 209.78 prem.  prem.
HUN Huntsman 25.34 prem.  prem.
KRO Kronos Worldwi 17.31 prem.  prem.
SHLM A. Schulman 27.50 prem.  prem.
OXY Occidental Pet 59.63 prem.  prem.
HON Honeywell Inte 132.93 prem.  prem.
VAL Valspar 112.99 prem.  prem.

COMPANY NEWS

▶ Top Ranked Value Stocks to Buy for June 27th   [Jun-27-17 11:20AM  Zacks]
▶ Behind Chemours Debt Development since Its Spin-Off   [Jun-26-17 04:40PM  Market Realist]
▶ A Strong Case for Selling Chemours Co.   [08:12AM  Motley Fool]
▶ Top Ranked Growth Stocks to Buy for June 23rd   [Jun-23-17 12:00PM  Zacks]
▶ Top Ranked Momentum Stocks to Buy for June 22nd   [Jun-22-17 10:58AM  Zacks]
▶ These Stocks Have Changed Direction   [Jun-19-17 02:00PM  TheStreet.com]
▶ ETFs with exposure to The Chemours Co. : June 15, 2017   [Jun-15-17 01:26PM  Capital Cube]
▶ 3 Stocks That Put NVIDIA Growth to Shame   [Jun-14-17 11:06AM  Motley Fool]
▶ These Stocks Have Quadrupled in 1 Year   [Jun-13-17 11:15AM  Motley Fool]
▶ Chemours Was Added to the Fortune 500 List   [07:38AM  Market Realist]
▶ Top Ranked Growth Stocks to Buy for June 9th   [Jun-09-17 11:29AM  Zacks]
▶ The Chemours Co. Value Analysis (NYSE:CC) : June 8, 2017   [Jun-08-17 02:08PM  Capital Cube]
▶ Top Ranked Growth Stocks to Buy for June 5th   [Jun-05-17 11:39AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for June 1st   [Jun-01-17 11:41AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for May 31st   [May-31-17 11:35AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for May 26th   [May-26-17 11:58AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for May 22nd   [May-22-17 09:56AM  Zacks]
▶ Top Ranked Growth Stocks to Buy for May 16th   [May-16-17 10:23AM  Zacks]
▶ Chemours to Raise $500 Million in Senior Notes   [May-15-17 11:51AM  Market Realist]
▶ Top Ranked Growth Stocks to Buy for May 12th   [May-12-17 10:37AM  Zacks]
▶ 3 Market-Beating Growth Stocks   [May-10-17 04:26PM  Zacks]
▶ Top Ranked Growth Stocks to Buy for May 8th   [May-08-17 10:30AM  Zacks]
▶ Which Companies Are Now Outperforming 95% Of All Stocks?   [12:20PM  Investor's Business Daily]
▶ Top Ranked Growth Stocks to Buy for May 2nd   [May-02-17 11:48AM  Zacks]
▶ Chemours posts 1Q profit   [May-01-17 06:26PM  Associated Press]
▶ Chemours Announces Second Quarter Dividend   [Apr-27-17 05:00PM  PR Newswire]
▶ Top Ranked Growth Stocks to Buy for April 21st   [Apr-21-17 10:39AM  Zacks]
Stock chart of CC Financial statements of CC Annual reports of CC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.